AVRICORE HEALTH INC (AVCR.CA) Fundamental Analysis & Valuation

TSX-V:AVCR • CA0545211090

0.07 CAD
0 (0%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AVCR.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Taking everything into account, AVCR scores 3 out of 10 in our fundamental rating. AVCR was compared to 10 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for AVCR as it has an excellent financial health rating, but there are worries on the profitability. AVCR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. AVCR.CA Profitability Analysis

1.1 Basic Checks

  • AVCR had negative earnings in the past year.
  • AVCR had a negative operating cash flow in the past year.
  • In the past 5 years AVCR always reported negative net income.
  • In multiple years AVCR reported negative operating cash flow during the last 5 years.
AVCR.CA Yearly Net Income VS EBIT VS OCF VS FCFAVCR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M -3M -4M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -122.49%, AVCR is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • The Return On Equity of AVCR (-125.89%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -122.49%
ROE -125.89%
ROIC N/A
ROA(3y)-29.53%
ROA(5y)-86.04%
ROE(3y)-36.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVCR.CA Yearly ROA, ROE, ROICAVCR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • AVCR has a Gross Margin (43.48%) which is comparable to the rest of the industry.
  • AVCR's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for AVCR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.52%
GM growth 5Y-2.21%
AVCR.CA Yearly Profit, Operating, Gross MarginsAVCR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. AVCR.CA Health Analysis

2.1 Basic Checks

  • AVCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AVCR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AVCR has more shares outstanding
  • AVCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AVCR.CA Yearly Shares OutstandingAVCR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AVCR.CA Yearly Total Debt VS Total AssetsAVCR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.2 Solvency

  • An Altman-Z score of 91.01 indicates that AVCR is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 91.01, AVCR is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • There is no outstanding debt for AVCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 91.01
ROIC/WACCN/A
WACC8.69%
AVCR.CA Yearly LT Debt VS Equity VS FCFAVCR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

2.3 Liquidity

  • A Current Ratio of 17.92 indicates that AVCR has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 17.92, AVCR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • A Quick Ratio of 17.81 indicates that AVCR has no problem at all paying its short term obligations.
  • The Quick ratio of AVCR (17.81) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 17.92
Quick Ratio 17.81
AVCR.CA Yearly Current Assets VS Current LiabilitesAVCR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. AVCR.CA Growth Analysis

3.1 Past

  • AVCR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1820.00%.
  • AVCR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -59.28%.
  • Measured over the past years, AVCR shows a very strong growth in Revenue. The Revenue has been growing by 170.57% on average per year.
EPS 1Y (TTM)-1820%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.56%
Revenue 1Y (TTM)-59.28%
Revenue growth 3Y239.04%
Revenue growth 5Y170.57%
Sales Q2Q%-96.85%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AVCR.CA Yearly Revenue VS EstimatesAVCR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

Find the best growth stocksShow best growing peers

0

4. AVCR.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • AVCR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVCR.CA Price Earnings VS Forward Price EarningsAVCR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVCR.CA Per share dataAVCR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AVCR.CA Dividend Analysis

5.1 Amount

  • No dividends for AVCR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AVCR.CA Fundamentals: All Metrics, Ratios and Statistics

AVRICORE HEALTH INC

TSX-V:AVCR (3/6/2026, 7:00:00 PM)

0.07

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)12-01
Earnings (Next)04-29
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.94%
Ins Owner ChangeN/A
Market Cap7.09M
Revenue(TTM)1.92M
Net Income(TTM)-1.63M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.69
P/FCF N/A
P/OCF N/A
P/B 5.48
P/tB 5.8
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.02
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -122.49%
ROE -125.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.48%
FCFM N/A
ROA(3y)-29.53%
ROA(5y)-86.04%
ROE(3y)-36.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.52%
GM growth 5Y-2.21%
F-Score4
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 47.74%
Cap/Sales 6.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.92
Quick Ratio 17.81
Altman-Z 91.01
F-Score4
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)316.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)34.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1820%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-59.28%
Revenue growth 3Y239.04%
Revenue growth 5Y170.57%
Sales Q2Q%-96.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-890.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-137.82%
OCF growth 3YN/A
OCF growth 5YN/A

AVRICORE HEALTH INC / AVCR.CA FAQ

What is the fundamental rating for AVCR stock?

ChartMill assigns a fundamental rating of 3 / 10 to AVCR.CA.


Can you provide the valuation status for AVRICORE HEALTH INC?

ChartMill assigns a valuation rating of 0 / 10 to AVRICORE HEALTH INC (AVCR.CA). This can be considered as Overvalued.


Can you provide the profitability details for AVRICORE HEALTH INC?

AVRICORE HEALTH INC (AVCR.CA) has a profitability rating of 1 / 10.


How financially healthy is AVRICORE HEALTH INC?

The financial health rating of AVRICORE HEALTH INC (AVCR.CA) is 8 / 10.